| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |